Northern Trust’s Oculis Holding OCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$286K Sell
20,623
-566
-3% -$12.8K ﹤0.01% 3824
2026
Q1
$563K Hold
21,189
﹤0.01% 3574
2025
Q4
$423K Sell
21,189
-615
-3% -$12.3K ﹤0.01% 3713
2025
Q3
$383K Sell
21,804
-1,515
-6% -$26.9K ﹤0.01% 3743
2025
Q2
$453K Sell
23,319
-513
-2% -$9.42K ﹤0.01% 3673
2025
Q1
$454K Buy
23,832
+10,267
+76% +$210K ﹤0.01% 3611
2024
Q4
$231K Hold
13,565
﹤0.01% 3937
2024
Q3
$166K Buy
+13,565
New +$160K ﹤0.01% 3937

Other funds holding OCS

Northern Trust's OCS Position: Q2 2026 in Review

Northern Trust reduced its Oculis Holding (OCS) stake by 2.7% in Q2 2026, selling an estimated $12.8K and leaving 20,623 shares worth $286K. The position accounts for ﹤0.01% of the portfolio, ranked #3824.

Northern Trust first reported a position in OCS in Q3 2024 and has held it in 8 quarters since. The position peaked at $563K in Q1 2026. 59 funds tracked by Wall St. Rank hold OCS as of Q2 2026.

  • Northern Trust held 20,623 shares of Oculis Holding worth $286K as of Q2 2026.
  • Northern Trust sold 566 Oculis Holding shares in Q2 2026, an estimated $12.8K.
  • Oculis Holding made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3824 holding.
  • Northern Trust first reported a position in Oculis Holding in Q3 2024 and has held it in 8 quarters since.
  • Northern Trust's Oculis Holding position peaked at $563K in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Oculis Holding as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.